Filing Details
- Accession Number:
- 0001140361-17-043114
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-16 16:53:09
- Reporting Period:
- 2017-11-14
- Accepted Time:
- 2017-11-16 16:53:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1444380 | Nevro Corp | NVRO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1417976 | H Andrew Galligan | C/O Nevro Corp. 1800 Bridgeway Parkway Redwood City CA 94065 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-11-14 | 13,000 | $0.00 | 28,192 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2017-11-14 | 7,000 | $18.00 | 35,192 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-11-14 | 7,000 | $75.11 | 28,192 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2017-11-14 | 26,000 | $0.00 | 26,000 | $76.81 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-11-14 | 7,000 | $0.00 | 7,000 | $18.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 26,000 | 2027-11-13 | No | 4 | A | Direct | |
| 35,463 | 2024-11-04 | No | 4 | M | Direct |
Footnotes
- Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs vest annually on November 1 of each year, beginning November 1, 2018, subject to the Reporting Person's continued service to the issuer.
- Includes 18,125 RSUs.
- The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.38, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- 1/48th of the shares subject to the option vest on each monthly anniversary measured from November 14, 2017 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- 1/48th of the shares subject to the option vest on each monthly anniversary measured from November 5, 2014 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Billionaire Hedge Funds
